Plexus CEO Todd Kelsey Sells $274,750 in Company Stock

Todd Kelsey, the Chief Executive Officer of Plexus Corp, sold $274,750 worth of company stock on 29 May 2026. The transaction was disclosed in a Form 4 filing with the Securities and Exchange Commission. Plexus stock closed at $115.00 per share on the day of the sale. The company's market capitalization stands at approximately $3.2 billion.

Context — [why this matters now]

Insider sales at Plexus have occurred periodically, but this sale by the CEO is the largest single-disclosure transaction since Kelsey sold $188,000 in shares in August 2025. The sale arrives as the technology hardware sector faces headwinds from elevated interest rates, which pressure capital expenditure budgets. The 10-year US Treasury yield was at 4.31% on the transaction date, a level that historically dampens valuation multiples for growth-oriented manufacturers. The immediate catalyst appears to be the stock's strong performance, having gained 47% over the preceding twelve months, potentially prompting portfolio rebalancing by executives.

This transaction is evaluated within a broader trend of insider activity across the electronics manufacturing services (EMS) peer group. In March 2026, the CFO of Jabil Inc sold approximately $450,000 in stock after a quarterly earnings beat. Benchmark comparisons are critical; while CEO sales can signal concerns, they are also a routine part of personal financial planning and compensation realization. The current macro backdrop is defined by the Federal Reserve's data-dependent stance, keeping financing costs for industrial clients elevated.

Data — [what the numbers show]

The sale involved 2,389 shares at a weighted average price of $115.00. Kelsey's remaining direct holdings post-transaction are 45,112 shares, valued at roughly $5.19 million. This sale reduced his direct ownership stake by 5.0%. The transaction value of $274,750 represents 0.0086% of Plexus's total market cap.

Metric	Pre-Sale (approx.)	Post-Sale (approx.)
Kelsey's Direct Holdings	47,501 shares	45,112 shares
Value of Direct Holdings	$5.46 million	$5.19 million

Year-to-date, Plexus shares are up 12%, outperforming the iShares U.S. Technology Hardware ETF (IYW), which is up 8% for the same period. The stock trades at a forward price-to-earnings ratio of 18.7, a premium to the sector median of 16.2, reflecting its niche in complex, low-volume manufacturing.

Analysis — [what it means for markets / sectors / tickers]

The sale may catalyze a re-rating of peer stocks like Sanmina Corp and Flex Ltd, as investors scrutinize their insider trading calendars for similar activity. A sustained pattern of selling across the EMS sector could signal an industry peak in near-term order visibility. The most direct second-order effect is a potential 50-100 basis points of underperformance for PLXS against the Philadelphia Semiconductor Index (SOX) over the next month, as the news filters through quant and sentiment-driven models.

A key limitation of this analysis is that the sale was likely executed under a pre-arranged 10b5-1 trading plan, which insulates it from accusations of trading on non-public information. The counter-argument is that CEOs often sell for liquidity reasons unrelated to corporate outlook. Current positioning data from the options market shows a slight skew toward put buying in PLXS, with the put/call ratio rising to 0.65 from its 20-day average of 0.52, indicating growing defensive hedging.

Outlook — [what to watch next]

Investors will monitor the next Plexus earnings report, scheduled for 24 July 2024, for commentary on forward guidance and any change in the CEO's equity compensation structure. The $110.50 price level, representing the 50-day moving average, is a key technical support to watch; a break below could accelerate selling.

Upcoming catalysts include the ISM Manufacturing PMI report on 3 June and the Federal Open Market Committee meeting on 18 June. Any dovish shift from the Fed that lowers terminal rate expectations would benefit capital-intensive sectors like technology hardware, potentially offsetting negative sentiment from insider sales. The stock's resistance sits near the recent high of $118.75.

Frequently Asked Questions

What is a 10b5-1 trading plan?

A 10b5-1 plan is a pre-established, written trading plan for corporate insiders to buy or sell stock at predetermined times or prices. It provides an affirmative defense against insider trading allegations by demonstrating the trades were planned before the insider possessed material non-public information. The existence of such a plan for CEO Kelsey's sale, while not confirmed in this filing, is a common practice that would significantly neuter the bearish signal of the transaction.

How does this sale compare to insider activity at other tech manufacturers?

Over the last quarter, aggregate insider selling at Plexus, measured by total dollar value, has been lower than at larger peers like Jabil and Flex. This relative moderation suggests company-specific factors, rather than a sector-wide loss of confidence, may be at play. For deeper context on sector capital flows, review our analysis on Fazen Markets covering industrial production trends.

What percentage of his total compensation does this sale represent?

Based on recent proxy statements, Todd Kelsey's annual total compensation, including salary, bonus, and stock awards, has averaged approximately $6.5 million. The $274,750 sale represents about 4.2% of that annual figure. This is a relatively small proportion, indicating the sale is more likely related to routine portfolio diversification or tax planning than a major shift in personal wealth allocation away from Plexus.

Bottom Line

The CEO's stock sale is a routine liquidity event amplified by the stock's strong recent performance, not a clear signal of deteriorating fundamentals.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.